These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Prognostic Factors in Guillain-Barré Syndrome]. Kaida K Brain Nerve; 2015 Nov; 67(11):1411-9. PubMed ID: 26560956 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of Guillain-Barré syndrome. Liu S; Dong C; Ubogu EE Hum Vaccin Immunother; 2018; 14(11):2568-2579. PubMed ID: 29953326 [TBL] [Abstract][Full Text] [Related]
17. Progress in Guillain-Barré syndrome immunotherapy-A narrative review of new strategies in recent years. Yao J; Zhou R; Liu Y; Lu Z Hum Vaccin Immunother; 2023 Aug; 19(2):2215153. PubMed ID: 37278272 [TBL] [Abstract][Full Text] [Related]
18. Role of Therapeutic Plasma Exchange in Guillain-Barre Syndrome after Allogeneic Hematopoietic Stem Cell Transplant: Report of Two Cases. Cekdemir D; Ozkan HA; Korkmaz F; Ozgurel Y; Kural S; Tiryaki N; Gulbas Z Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739028 [TBL] [Abstract][Full Text] [Related]
19. Advances in the management of Guillain-Barré syndrome. Green DM Curr Neurol Neurosci Rep; 2002 Nov; 2(6):541-8. PubMed ID: 12359110 [TBL] [Abstract][Full Text] [Related]
20. Treatment dilemmas in Guillain-Barré syndrome. Verboon C; van Doorn PA; Jacobs BC J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):346-352. PubMed ID: 27837102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]